- Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Thomas Grobner
Department of Nephrology, General Hopsital of Wiener Neustadt, A 2700 Wiener Neustadt, Austria
Nephrol Dial Transplant 21:1104-8. 2006
- Gadolinium and nephrogenic systemic fibrosisT Grobner
12nd Department of Medicine Nephrology, General Hospital of Wiener Neustadt, Wiener Neustadt, Austria
Kidney Int 72:260-4. 2007..In this short review, the development of NSF and its sequential association with the exposure to gadolinium-containing contrast agents is presented. The mechanisms likely to cause NFD/NSF are discussed...
- Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposureThomas Grobner
2nd Department of Medicine Nephrology, General Hospital of Wiener Neustadt, Wiener Neustadt, Austria
Semin Dial 21:135-9. 2008..Other potential risk factors include metabolic acidosis, iron overload/intravenous iron, divalent ion disturbances, endothelial/vascular injury, and high erythropoietin doses. Further studies are required...
- Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?Alexander R Rosenkranz
Clinical Division of Nephrology, Innsbruck Medical University, Innsbruck, Austria
Wien Klin Wochenschr 119:271-5. 2007